# MIDAZOLAM
> **ANDA216048** · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA LTD · Approved 2022-11-01
## Drug
- **FDA Application Number:** ANDA216048
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MIDAZOLAM
- **Generic name:** Midazolam
- **Active ingredients:** MIDAZOLAM
- **Dosage form:** SPRAY
- **Route:** NASAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** CIPLA LTD
- **First approval:** 2022-11-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216048)
---
*AI Analytics · CC0 1.0*